| Expression pattern: |
UP |
| Associated gene: |
EOGT |
| Associated microRNA: |
hsa-miR-130a-3p |
| Biological function: |
Promotes HCC progression and sorafenib resistance. |
| Molecular mechanism: |
Acts as a molecular sponge for hsa-miR-130a-3p to derepress EOGT (ceRNA model) in an exosome-associated context. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); drug resistance (promotes) |
| Detected method: |
M
|
| Validation methods: |
Microarray; Bioinformatics Analysis |
| Clinical significance: |
Potential dual diagnostic and therapeutic resistance biomarker (upregulated in HCC tissues, plasma, and exosomes from sorafenib-resistant cells). |
| Description: |
hsa_circ_0058189 is upregulated in HCC tissues and patient plasma and is enriched in exosomes from sorafenib-resistant HepG2 cells. It is proposed to promote HCC progression and sorafenib resistance by sponging hsa-miR-130a-3p, thereby relieving repression of EOGT in a ceRNA axis. |
| Confidence score: |
0.1768 |